#Pharmaceuticals

2026-11-06. The following slide deck was published by Rigel Pharmaceuticals, Inc.

ARS Pharmaceuticals' neffy faces slow adoption and insurance hurdles but shows potential for significant market share and revenue. Read why SPRY stock is a Buy.

2026-10-27. The following slide deck was published by Kiniksa Pharmaceuticals International, plc in conjunction with their 2026 Q3 earnings call.

A simple liquid painted onto teeth in seconds can stop cavities without drilling, injections, or anesthesia, according to a major clinical trial involving young children.…

2026-10-23. The following slide deck was published by Vertex Pharmaceuticals Incorporated in conjunction with this event.

USC researchers have identified potential new drug compounds that may reduce the brain inflammation linked to Alzheimer’s disease, especially in people with the high-risk APOE4 gene.…

The current medical system has been criticized for allowing drugs that could be replaced by over-the-counter alternatives to be bought for cheaper through public health insurance.

The space startup is collaborating with United Therapeutics Corporation to manufacture commercial drugs in orbit.

For some experts, the outbreak is raising broader concerns about how equipped the U.S. is to respond to future infectious disease threats.

Scientists at UBC Okanagan have uncovered how plants produce mitraphylline, a rare natural compound with promising anti cancer potential. The team identified two enzymes that work together to build the molecule’s unusual twisted structure, solving a…

Scientists at the University of Maryland, Baltimore County, have uncovered a crucial trick used by enteroviruses—the group behind diseases like polio, myocarditis, encephalitis, and even the common cold—to reproduce inside human cells.…

The results mark the first late-stage success for an oral antiviral used to prevent COVID-19 after exposure.

Makary's tenure was marked by internal dysfunction at the FDA, leadership turmoil and mounting backlash from drugmakers and physicians on regulatory decisions.

The Japanese drugmaker aims to more than double oncology revenue to above ¥2.3 trillion by 2030 and become one of the world's top five oncology players by 2035.

The outbreak of Hantavirus on a cruise ship has led to biotech and pharmaceutical stocks surging on reports of firms developing vaccines.

A little-known tree from Brazil’s Atlantic Forest may hold a surprising weapon against COVID-19. Researchers discovered that compounds called galloylquinic acids, extracted from its leaves, can attack SARS-CoV-2 on multiple fronts—blocking the virus from…

All of the health-care giant's business segments, including its insurer Aetna, its retail pharmacy and health services unit, surpassed expectations.

Novo Nordisk raised its outlook for 2026 after a strong performance from its newly launched Wegovy pill.

The studies were "withdrawn because the authors drew broad conclusions that were not supported by the underlying data," the spokesperson told CNBC.

From CNBC: Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth